| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4da51240309dc01cd248e0e244a3cd70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-79 |
| filingDate |
1972-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1973-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49133708172cea2464c5fab12ade961e |
| publicationDate |
1973-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3770753-A |
| titleOfInvention |
Beta-pyridyl carbinol nicotinoyl glycinate |
| abstract |
THE PRESENT INVENTION PROVIDES THE NEW COMPOUND (BETA-PYRIDYL CARBINOL) NICOTINOYL GLYCINATE, WHICH HAS THE FORMULA: 3-((PYRID-3-YL)-CO-NH-CH2-COO-CH2-)PYRIDINE THIS COMPOUND IS TO BE USED IN DRUGS FOR THE TREATMENT OF CEREBRAL ARTERIOSCLEROSIS AND OF ANY FORM OF ARTERIOPATHIES. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3987175-A |
| priorityDate |
1972-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |